PSMD12 is a novel potential biomarker for lung adenocarcinoma and associated with prognosis in lung adenocarcinoma patients

Journal of Cardiothoracic Surgery · Published 2026-08-03 · DOI 10.1186/s13019-026-04601-z

Free full text

Authors (8)

Shuyu Lu, Yue Li, Huajian Peng, Xiang Gao, Zhanyu Xu, Huafu Zhou, Jianji Guo, Nuo Yang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Lu, S., Li, Y., Peng, H., et al. (2026). PSMD12 is a novel potential biomarker for lung adenocarcinoma and associated with prognosis in lung adenocarcinoma patients. Journal of Cardiothoracic Surgery. https://doi.org/10.1186/s13019-026-04601-z

Related articles